CC
AZN icon

Courier Capital’s AstraZeneca AZN Stock Holding History

Courier Capital’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$968K Sell
5,104
-100
-2% -$18.8K 0.05% 219
2026
Q1 		$1.03M Buy
5,204
+15
+0.3% +$2.89K 0.06% 214
2025
Q4 		$954K Hold
5,189
– – 0.05% 217
2025
Q3 		$796K Sell
5,189
-1,062
-17% -$161K 0.05% 233
2025
Q2 		$874K Buy
6,251
+1,068
+21% +$150K 0.05% 219
2025
Q1 		$762K Buy
5,183
+537
+12% +$77.7K 0.05% 225
2024
Q4 		$609K Sell
4,646
-13
-0.3% -$1.82K 0.04% 233
2024
Q3 		$726K Sell
4,659
-200
-4% -$32.3K 0.05% 215
2024
Q2 		$758K Hold
4,859
– – 0.06% 193
2024
Q1 		$658K Hold
4,859
– – 0.05% 216
2023
Q4 		$654K Hold
4,859
– – 0.05% 216
2023
Q3 		$658K Hold
4,859
– – 0.05% 215
2023
Q2 		$695K Hold
4,859
– – 0.05% 212
2023
Q1 		$674K Sell
4,859
-150
-3% -$20.2K 0.07% 148
2022
Q4 		$679K Hold
5,009
– – 0.08% 141
2022
Q3 		$549K Hold
5,009
– – 0.07% 158
2022
Q2 		$662K Hold
5,009
– – 0.08% 148
2022
Q1 		$665K Hold
5,009
– – 0.07% 159
2021
Q4 		$583K Hold
5,009
– – 0.05% 175
2021
Q3 		$602K Buy
5,009
+40
+0.8% +$4.66K 0.06% 171
2021
Q2 		$595K Sell
4,969
-500
-9% -$54.9K 0.06% 172
2021
Q1 		$544K Hold
5,469
– – 0.05% 173
2020
Q4 		$547K Buy
5,469
+50
+0.9% +$5.3K 0.06% 167
2020
Q3 		$602K Buy
5,419
+450
+9% +$50.1K 0.07% 153
2020
Q2 		$535K Sell
4,969
-132
-3% -$13.6K 0.07% 157
2020
Q1 		$511K Buy
5,101
+132
+3% +$12.4K 0.08% 141
2019
Q4 		$498K Hold
4,969
– – 0.06% 172
2019
Q3 		$429K Hold
4,969
– – 0.06% 181
2019
Q2 		$410K Sell
4,969
-40
-0.8% -$3.14K 0.05% 185
2019
Q1 		$405K Hold
5,009
– – 0.05% 178
2018
Q4 		$380K Hold
5,009
– – 0.06% 173
2018
Q3 		$396K Buy
5,009
+40
+0.8% +$3.02K 0.05% 192
2018
Q2 		$349K Hold
4,969
– – 0.05% 220
2018
Q1 		$347K Hold
4,969
– – 0.05% 211
2017
Q4 		$345K Hold
4,969
– – 0.04% 212
2017
Q3 		$337K Buy
4,969
+557
+13% +$35.2K 0.05% 199
2017
Q2 		$301K Hold
4,412
– – 0.05% 209
2017
Q1 		$275K Hold
4,412
– – 0.05% 208
2016
Q4 		$241K Sell
4,412
-1,050
-19% -$59.6K 0.05% 228
2016
Q3 		$359K Hold
5,462
– – 0.07% 189
2016
Q2 		$330K Sell
5,462
-58
-1% -$3.37K 0.07% 208
2016
Q1 		$311K Buy
5,520
+885
+19% +$53.2K 0.06% 208
2015
Q4 		$315K Buy
4,635
+811
+21% +$53.2K 0.07% 200
2015
Q3 		$243K Sell
3,824
-57
-1% -$3.75K 0.05% 225
2015
Q2 		$247K Sell
3,881
-85
-2% -$5.82K 0.05% 232
2015
Q1 		$271K Hold
3,966
– – 0.05% 218
2014
Q4 		$279K Hold
3,966
– – 0.06% 218
2014
Q3 		$283K Sell
3,966
-135
-3% -$9.88K 0.06% 216
2014
Q2 		$305K Sell
4,101
-35
-0.8% -$2.53K 0.06% 220
2014
Q1 		$268K Buy
4,136
+380
+10% +$24.5K 0.06% 224
2013
Q4 		$223K Sell
3,756
-150
-4% -$8.15K 0.05% 242
2013
Q3 		$203K Buy
+3,906
New +$196K 0.05% 258

Other funds holding AZN

RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
CDDEC
Caisse Des Depots Et Consignations Paris, France $5.91B AUM 35.65% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
BTCPP
Border to Coast Pensions Partnership Leeds, United Kingdom $6.78B AUM 31.6% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
ISS
Intesa Sanpaolo SpA. Turin, Italy $2.92B AUM
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Courier Capital's AZN Position: Q2 2026 in Review

Courier Capital reduced its AstraZeneca (AZN) stake by 1.9% in Q2 2026, selling an estimated $18.8K and leaving 5,104 shares worth $968K. The position accounts for 0.05% of the portfolio, ranked #219.

Courier Capital first reported a position in AZN in Q3 2013 and has held it in 52 quarters since. The position peaked at $1.03M in Q1 2026. 641 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Courier Capital held 5,104 shares of AstraZeneca worth $968K as of Q2 2026.
  • Courier Capital sold 100 AstraZeneca shares in Q2 2026, an estimated $18.8K.
  • AstraZeneca made up 0.05% of Courier Capital's portfolio in Q2 2026, its #219 holding.
  • Courier Capital first reported a position in AstraZeneca in Q3 2013 and has held it in 52 quarters since.
  • Courier Capital's AstraZeneca position peaked at $1.03M in Q1 2026.
  • 641 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Courier Capital's 13F filing for Q2 2026, filed 16 Jul 2026.